IDRI is a Seattle-based not-for-profit organization committed to applying innovative science to the research and development of products to prevent, detect, and treat infectious diseases of poverty.

IDRI partners for small-scale formulation and aseptic filling of liquid drug products for preclinical and Phase 1 & 2 clinical studies. The company performs cGMP manufacturing in their state-of-the-art clean rooms in compliance with U.S. and EU regulations.

The filling is done with an automated filling, stoppering and capping machine or in a semi-automatic operation. The semi-automatic option is typically used for the manufacture of small batches.

Drug product sterilization can be done aseptically (filtration through 0.22 µm filter) or terminally (autoclaving). Their services are individualized and performed with flexibility per our customers’ needs.